Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Surmodics, Inc.

< Previous 1 2 Next >
Surmodics Provides Regulatory Update on its Strategy to Submit an Amended Premarket Approval Application for the SurVeil™ Drug-Coated Balloon
From Surmodics, Inc.
Via Business Wire
Tickers SRDX
Surmodics to Participate in Upcoming Investor Conferences in March
From Surmodics, Inc.
Via Business Wire
Tickers SRDX
Surmodics Reports First Quarter of Fiscal Year 2023 Financial Results; Updates Fiscal Year 2023 Financial Guidance
From Surmodics, Inc.
Via Business Wire
Tickers SRDX
Surmodics to Host Virtual Annual Meeting of Shareholders
From Surmodics, Inc.
Via Business Wire
Tickers SRDX
Surmodics to Report First Quarter of Fiscal 2023 Financial Results on February 6
From Surmodics, Inc.
Via Business Wire
Tickers SRDX
Differentiated Capabilities of Surmodics’ Crystalline Drug Release Platform for Sirolimus-Coated Balloons Presented at ISET Conference
From Surmodics, Inc.
Via Business Wire
Tickers SRDX
Surmodics Provides Regulatory Update Related to its FDA Premarket Approval Application for the SurVeil™ Drug-Coated Balloon
From Surmodics, Inc.
Via Business Wire
Tickers SRDX
Surmodics Announces SWING Trial 12-Month Data to be Presented at ISET Conference on January 18
From Surmodics, Inc.
Via Business Wire
Tickers SRDX
Surmodics Announces 12-Month Data from the SWING Trial Presented at VEITHsymposium
From Surmodics, Inc.
Via Business Wire
Tickers SRDX
Surmodics Announces SWING Trial 12-Month Data to be Presented at VEITHsymposium on November 16
From Surmodics, Inc.
Via Business Wire
Tickers SRDX
Surmodics Reports Fourth Quarter and Fiscal Year 2022 Financial Results; Introduces Fiscal Year 2023 Financial Guidance
From Surmodics, Inc.
Via Business Wire
Tickers SRDX
24-Month Data from Surmodics’ TRANSCEND Trial Presented at VIVA 2022 Conference
From Surmodics, Inc.
Via Business Wire
Tickers SRDX
Surmodics to Report Fourth Quarter and Fiscal Year 2022 Financial Results on November 9th
From Surmodics, Inc.
Via Business Wire
Tickers SRDX
Surmodics Announces TRANSCEND Trial 24-Month Data to be Presented at VIVA 2022
From Surmodics, Inc.
Via Business Wire
Tickers SRDX
Surmodics Announces New Credit Facilities Providing up to $125 Million in Financing
From Surmodics, Inc.
Via Business Wire
Tickers SRDX
6-Month Data from the Surmodics SWING BTK First-in-Human Trial Presented at AMP Europe
From Surmodics, Inc.
Via Business Wire
Tickers SRDX
6-Month Data from the Surmodics SWING First-in-Human Study to be Presented at AMP Europe
From Surmodics, Inc.
Via Business Wire
Tickers SRDX
Surmodics to Present at Upcoming Gilmartin Emerging Growth Company Showcase Wednesday, August 31, 2022
From Surmodics, Inc.
Via Business Wire
Tickers SRDX
Surmodics Reports Third Quarter Fiscal 2022 Results
From Surmodics, Inc.
Via Business Wire
Tickers SRDX
Surmodics to Webcast Third Quarter Fiscal 2022 Earnings Conference Call on July 27
From Surmodics, Inc.
Via Business Wire
Tickers SRDX
Surmodics to Present at Jefferies Healthcare Conference
From Surmodics, Inc.
Via Business Wire
Tickers SRDX
Surmodics Reports Second Quarter Fiscal 2022 Results
From Surmodics, Inc.
Via Business Wire
Tickers SRDX
Pounce™ Thrombectomy System First-in-Human Data Show 100 Percent Technical Success in Early Cases
From Surmodics, Inc.
Via Business Wire
Tickers SRDX
Dr. Gary Ansel to Present Pounce™ Thrombectomy System First-in-Human Data at Charing Cross Symposium
From Surmodics, Inc.
Via Business Wire
Tickers SRDX
Surmodics to Webcast Second Quarter Fiscal 2022 Earnings Conference Call on April 27
From Surmodics, Inc.
Via Business Wire
Tickers SRDX
Surmodics to Host Virtual Annual Meeting of Shareholders
From Surmodics, Inc.
Via Business Wire
Tickers SRDX
Surmodics Reports First Quarter Fiscal 2022 Results
From Surmodics, Inc.
Via Business Wire
Tickers SRDX
Surmodics to Webcast First Quarter Fiscal 2022 Earnings Conference Call on February 3
From Surmodics, Inc.
Via Business Wire
Tickers SRDX
Surmodics to Present at Sidoti & Company Virtual Investor Conference
From Surmodics, Inc.
Via Business Wire
Tickers SRDX
Surmodics Reports Fourth Quarter Fiscal 2021 Results and Issues Fiscal 2022 Revenue and EPS Guidance
From Surmodics, Inc.
Via Business Wire
Tickers SRDX
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.